Home / Market / Company Snapshot

Dishman Pharmaceuticals and Chemicals Ltd

HSL Code: DISPHA | BSE Code: 532526 | NSE Symbol: DISHMAN | ISIN: INE353G01020

Fetching Data...

research reports

No Record Found.

news

Apr11	Corporate News on Thursday 14:37 Dishman Pharmaceuticals and Chemicals to consider final dividend 619562
Feb11	Results - Announcements on Monday 17:29 Dishman Pharmaceuticals and Chemicals net profit declines 61.59% in the December 2012 quarter 607582
Nov2	Results - Announcements on Friday 17:05 Dishman Pharmaceuticals and Chemicals reports net profit of Rs 10.61 crore in the September 2012 quarter 588605
Sep13	Hot Pursuit on Thursday 13:29 Dishman Pharma drops ex-dividend 580004
Aug1	Hot Pursuit on Wednesday 10:21 Dishman Pharma spurts 17.15% in two trading days on stellar Q1 outcome 570356

Key Ratios

Market Cap (Rs. in Cr.)	579.83
Book Value	114.60
EPS (TTM)	14.00
Price/Book	0.63
Face value	2.00
P/E	5.13
Div(%)	60.00
Div Yield(%)	1.67

Fetching Data...

Rs. Cr.	Dec 12	Sep 12	Jun 12
Total Income	329.27	298.36	317.92
Total Expenses	260.89	231.04	231.70
EBITDA	68.38	67.32	86.22
EBIT	47.67	46.90	66.87
PBT	22.47	33.66	43.74
PAT	16.41	26.57	38.70
Net Profit	16.41	26.60	38.70

Values Based on Consolidated Data

Peer Group

More Compare

Lupin (NSE) 768.35(-4.39%)
Divi`s Lab. (NSE) 1,082.20(-3.43%)
Jubilant Life (NSE) 156.10(-1.73%)
Shilpa Medicare (NSE) 303.50(4.57%)
Hikal (NSE) 421.50(3.13%)

Shareholding Pattern

	Promoters	61.37%
	Mutual Funds / UTI	3.73%
	FI / Banks	2.42%
	Insurance	0.00%
	Government	0.00%
	FII	9.10%
	Others	23.39%

Announcements & Events

Announcements
events

Apr5	Dishman Pharmaceuticals and Chemicals Limited - Disclosure under SEBI Takeover Regulations
Mar14	Dishman Pharmaceuticals and Chemicals Limited - Disclosure under SEBI Takeover Regulations
Mar5	Dishman Pharmaceuticals and Chemicals Limited - Disclosure under SEBI Takeover Regulations
Mar4	Dishman Pharmaceuticals and Chemicals Limited - Disclosure under SEBI Takeover Regulation
Feb28	Dishman Pharmaceuticals and Chemicals Limited - Disclosure under SEBI Takeover Regulations

MF holdings

Scheme Name	%AUM	CMV(Rs. Cr)
HDFC Mid-Cap Opportunities Fund (G)	0.50	13.71
HDFC Tax Saver Fund (D)	0.09	3.03
BNP Paribas Tax Advantage Plan (ELSS) (G)	0.41	0.51
UTI-Pharma & Healthcare Fund (D)	0.36	0.40
BNP Paribas Mid Cap Fund (G)	0.71	0.31

Exchange Information

NSE Indices		BSE Indices
Nifty		Sensex
CNX 100		BSE 100
CNX 200		BSE 200
S&P CNX 500		BSE 500
CNX Midcap		BSE Mid-Cap
CNX Midcap 50		BSE Small-Cap

Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Comparative performance

	1M (%)	3M (%)	6M (%)
Dishman Pharmaceuticals and Chemicals Ltd	5.90	-11.19	-36.91
NIFTY (S&P CNX)	8.76	4.17	11.05
BSE Sensex	8.30	3.31	10.62
BSE 500	8.24	2.56	8.33

F & O Quotes

Futures
Options

Expiry Date

No Record Found.

Key Personnel
Janmejay R Vyas Chairman & Managing Director Deohooti J Vyas Whole-time Director Yagneshkumar B Desai Director

Key Address

Registered Office:
Dishman Pharma.
Bhadr-Raj Chambers,
Swastik Cross Road Navrangpura,
Ahmedabad,
Gujarat.
Tel : 91-79-26443053/26445807
Fax : 91-79-26420198

Email : dishman:dishmangroup.com
Website : http://www.dishmangroup.com

Registrars Details
Link Intime India Pvt Ltd.
Add. :C-13 Pannalal Silk,
Mills Cmpd LBS Marg, Bhandup West,
Mumbai - 400 078.